Stay updated on Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:53:52.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. It appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-26T14:38:58.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T14:28:45.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:36:19.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, indicating access to the record is blocked. This results in the usual study details being unavailable and the page showing an error state instead.
    Difference
    18%
    Check dated 2026-09-21T20:52:23.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page’s revision history now shows Revision: v3.6.6, replacing v3.6.5, which indicates a backend or metadata update while the study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-08-31T16:16:06.000Z thumbnail image

Stay in the know with updates to Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.